PMID: 6396911Dec 1, 1984Paper

Malaria chemoprophylaxis for multiple drug resistant Plasmodium falciparum in Africa: an increasing problem

Tropical and Geographical Medicine
H J van der KaayP J Wismans

Abstract

Resistance of P. falciparum to the two groups of antimalaria drugs commonly used for prophylaxis, i.e. folate antagonists and 4-aminoquinolines has become a matter of great concern, also in Africa. After 1978, P. falciparum developed resistance to the group of 4-aminoquinolines, which was first reported from East Africa. Chloroquine resistant infections are now spreading into Central Africa. Similar developments are now appearing with the combination sulfadoxine/pyrimethamine. With the increasing reports of multiple drug resistance in P. falciparum from Africa, no single drug or combination of drugs in use for chemoprophylaxis can give a complete protection under all circumstances any longer. Until new effective drugs become available, it is advised to use the combination of chloroquine or amodiaquine and proguanil; the traveller should be prepared for action in the event of a breakthrough. A written instruction is suggested to be inserted in the "International Certificate of Vaccination".

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.